JP2024529291A5 - - Google Patents
Info
- Publication number
- JP2024529291A5 JP2024529291A5 JP2024500046A JP2024500046A JP2024529291A5 JP 2024529291 A5 JP2024529291 A5 JP 2024529291A5 JP 2024500046 A JP2024500046 A JP 2024500046A JP 2024500046 A JP2024500046 A JP 2024500046A JP 2024529291 A5 JP2024529291 A5 JP 2024529291A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163203026P | 2021-07-06 | 2021-07-06 | |
| US63/203,026 | 2021-07-06 | ||
| US202263349364P | 2022-06-06 | 2022-06-06 | |
| US63/349,364 | 2022-06-06 | ||
| PCT/US2022/073476 WO2023283586A2 (en) | 2021-07-06 | 2022-07-06 | Compositions and methods for treating and preventing viral infections |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024529291A JP2024529291A (ja) | 2024-08-06 |
| JP2024529291A5 true JP2024529291A5 (https=) | 2025-07-11 |
| JPWO2023283586A5 JPWO2023283586A5 (https=) | 2025-07-11 |
Family
ID=84802047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500046A Pending JP2024529291A (ja) | 2021-07-06 | 2022-07-06 | ウイルス感染症の処置および予防のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240327339A1 (https=) |
| EP (1) | EP4367086A4 (https=) |
| JP (1) | JP2024529291A (https=) |
| AU (1) | AU2022309236A1 (https=) |
| CA (1) | CA3224519A1 (https=) |
| WO (1) | WO2023283586A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117100743B (zh) * | 2023-08-21 | 2026-03-31 | 海南大学 | 一种倍半萜内酯类化合物在制备抗病毒药物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS597198A (ja) * | 1982-06-16 | 1984-01-14 | ビ−チヤム・グル−プ・ピ−エルシ− | ２′−デオキシウリジン化合物、その製造方法及びそれを有する製薬組成物 |
| AU771876B2 (en) * | 1998-07-27 | 2004-04-01 | Meiji Seika Kaisha Ltd. | Novel carbapenem derivatives |
| WO2004099127A1 (en) * | 2003-05-07 | 2004-11-18 | Novo Nordisk A/S | Novel compounds as kinase inhibitors |
| WO2012142492A2 (en) * | 2011-04-15 | 2012-10-18 | University Of Georgia Research Foundation, Inc. | Methods for inhibiting virus replication |
| RU2014121984A (ru) * | 2011-10-31 | 2015-12-10 | Ксенон Фармасьютикалз Инк. | Бензолсульфонамидные соединения и их применение в качестве терапевтических средств |
| WO2015196323A1 (zh) * | 2014-06-23 | 2015-12-30 | 北京新天宇科技开发有限公司 | 2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸的新型衍生物、其制备方法和应用 |
| WO2016017826A1 (ja) * | 2014-07-30 | 2016-02-04 | 帝人ファーマ株式会社 | キサンチンオキシダーゼ阻害薬 |
| JP7640458B2 (ja) * | 2018-10-05 | 2025-03-05 | アンナプルナ バイオ インコーポレイテッド | Ａｐｊ受容体活性に関連する状態を処置するための化合物および組成物 |
| WO2021207606A1 (en) * | 2020-04-10 | 2021-10-14 | University Of Georgia Research Foundation, Inc. | Methods for treatment of coronavirus infections |
| US11116737B1 (en) * | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
-
2022
- 2022-07-06 JP JP2024500046A patent/JP2024529291A/ja active Pending
- 2022-07-06 EP EP22838570.4A patent/EP4367086A4/en active Pending
- 2022-07-06 WO PCT/US2022/073476 patent/WO2023283586A2/en not_active Ceased
- 2022-07-06 AU AU2022309236A patent/AU2022309236A1/en active Pending
- 2022-07-06 US US18/577,631 patent/US20240327339A1/en active Pending
- 2022-07-06 CA CA3224519A patent/CA3224519A1/en active Pending